Headlands Technologies LLC Eagle Pharmaceuticals, Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$4.26 - $6.51 $12,187 - $18,625	2,861 Added 75.69%	6,641 $34,000
Q4 2023 Feb 02, 2024	BUY	$4.63 - $15.21 $6,732 - $22,115	1,454 Added 62.51%	3,780 $19,000
Q3 2023 Nov 09, 2023	BUY	$15.21 - $22.88 $25,644 - $38,575	1,686 Added 263.44%	2,326 $36,000
Q2 2023 Aug 03, 2023	BUY	$17.74 - $31.87 $11,353 - $20,396	640 New	640 $12,000

9.89M

1.01M

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $27.9M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.